Rising to the Challenges of Rare Disease Treatment
Soligenix, Inc. (NASDAQ:SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, such as Cutaneous T-Cell Lymphoma and Pediatric Crohn’s disease. emagine partnered with Soligenix to modernize their web presence and effectively feature their important research.
The emagine and Soligenix teams worked closely together to launch a website on a tight timeline with strong collaboration. From kickoff to launch, the collaborative partnership between Soligenix and emagine shone on this project. emagine’s UX and creative teams illustrated Soligenix’s work in an approachable and user-friendly manner, and we strategized on content development to ensure an optimal final output. The result was a lively site where the science came to life and explained to all users in plain language the importance of the research.